Skip to main content

Health economic modeling for medical technologies in Europe

Early and comprehensive economic models to determine economic value proposition and inform healthcare decision-makers

Learn more
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Early Health Economic Models Just Got More Affordable at MTRC

Health economic evidence is essential to support market access and commercialization of medical technologies in Europe and globally. 

Driven by the substantial productivity growth and increase in the size of the team, MTRC now offers a flexible, three-tier system - Start-up, Basic, and Comprehensive, for health economic models to medical device, in-vitro diagnostic, and digital technology companies:

  • Start-up – with no or limited evidence, suitable for marketing / clinical engagement
  • Basic – with limited evidence, presentable as conference poster, suitable for marketing / clinical engagement
  • Comprehensive – with limited to good evidence, suitable for HTA / reimbursement submissions

For the lowest tiers, MTRC offers very affordable prices of 13,500 and 21,500 euros. 

Health economic analysis of a medical device isn’t simple: costing index procedure across many EU countries, handling costs of capital equipment, device replacement and learning curve, incorporating sequential diagnostics are methodologically challenging. MTRC, Europe’s market access specialist, converts that tangle into payerready economic models and publications that clear reimbursement hurdles fast.

Learn more and contact us to discuss your needs here.